| Trial ID: | L0785 |
| Source ID: | NCT03731741
|
| Associated Drug: |
Pentoxifylline
|
| Title: |
Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients?
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Anemia of Chronic Kidney Disease
|
| Interventions: |
DRUG: Pentoxifylline
|
| Outcome Measures: |
Primary: hemoglobin difference, the difference in haemoglobin concentration between the pentoxifylline and control group at the end of the 6 months study period., after 6 months from the start | Secondary: difference in inflammatory markers, Difference in CRP and albumin levels between the two groups, after 6 months from the start
|
| Sponsor/Collaborators: |
Sponsor: Tanta University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
57
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2017-11-01
|
| Completion Date: |
2018-05-04
|
| Results First Posted: |
|
| Last Update Posted: |
2018-11-08
|
| Locations: |
Tanta university hospital, Tanta, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT03731741
|
